Vor Biopharma (VOR) said Friday it expects to raise about $55.6 million in gross proceeds from a private placement of 55.9 million shares, and warrants for 69.8 million shares at a combined price of $0.99425 per share and warrant.
The company said the seven-year warrants, exercisable at $0.838 per share, could yield an additional $58.5 million if exercised. The financing, led by new investor Reid Hoffman and existing shareholder RA Capital Management, includes provisions for each to gain representation on the board, Vor said.
Vor Bio said it plans to use the net proceeds from the placement, slated to close around Dec. 30, for clinical and preclinical development and corporate purposes.
The company also said it expects to provide updates on trials involving its VBP301 and VBP101 pipeline candidates in 2025.
Shares of the company were up more than 16% ahead of Friday's opening bell.
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。